Literature DB >> 19182410

Structure-activity relationship of bis-galloyl derivatives related to (-)-epigallocatechin gallate.

Kosuke Dodo1, Taro Minato, Yuichi Hashimoto.   

Abstract

Green tea and (-)-epigallocatechin gallate (EGCG: one of main components of green tea) are well known to have preventive activities against human cancers. Previously, using a galloyl group as a core structure derived from EGCG, we developed alkyl gallate and gallamide derivatives, which showed strong antiproliferative activity towards human leukemia HL-60 cells by inducing apoptosis. Here, as a further structural development study, we planned to introduce an additional galloyl group into alkyl gallates and gallamides. According to this strategy, various bisgallate and bisgallamide derivatives were synthesized and tested for antiproliferative activity towards HL-60 cells. In gallamide derivatives having a short alkyl chain, the additional galloyl group enhanced the antiproliferative activity. In contrast, in the gallate derivatives, the additional galloyl group had no effect on the antiproliferative activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182410     DOI: 10.1248/cpb.57.190

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

Review 1.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 2.  Recent advances on tea polyphenols.

Authors:  Jyoti Kanwar; Mujtaba Taskeen; Imthiyaz Mohammad; Congde Huo; Tak Hang Chan; Qing Ping Dou
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

3.  Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors.

Authors:  Nelson Ferreira; Alda Pereira-Henriques; Maria Rosário Almeida
Journal:  Biochem Biophys Rep       Date:  2015-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.